Press release
Acne Treatment Market is Expected to Reach US$ 10.8 Bn byThe End of 2031, With Sales Revenue Expected to Register 6% CAGR
As per Persistence Market Research's latest revised industry analysis, the global acne treatment market was valued at over US$ 5.8 Bn in 2020, and is expected to exhibit a CAGR of close to 6% over the forecast period (2022-2031).In the United States, acne affects approximately 50 million people annually. Increasing rate of skin diseases is one of the major factors boosting market growth globally. Acne is most commonly observed among teenagers, but can also be observed in people across all age groups.
According to the American Academy of Dermatology Association, over 85% of the population between the ages 12 and 24 have suffered from minor acne at least once or twice, and this may continue into individuals in their '30s and '40s
Significant prevalence of acne has led to increased awareness of considering skin treatment. This, in turn, is expected to fuel demand for acne treatment products. As new drugs and treatments are required to replace older methods such as antibiotics, acne research & development generates avenues and opportunities for players in the market. As a result, various industry players are receiving approvals from regulatory authorities.
Some of the recent approvals include AKLIEF (trifarotene) 0.005% cream (October 2019, Galderma SA), ARAZLO (tazarotene) Lotion, 0.045% (Bausch Health Companies Inc., December 2019), and ACZONE (DAPSONE) GEL (September 2019, Almirall S.A.). Thus, growing approvals support a positive outlook for continued healthy market growth.
Request for Sample Report of Acne Treatment @ https://www.persistencemarketresearch.com/samples/5279
Company Profile's:
• Galderma S.A.
• Lumenis Ltd
• Alma Lasers, Sisram Medical Company
• Cutera Inc.
• Almirall, S.A
• Johnson & Johnson Services Inc.
• Bausch Health Companies Inc.
• Teva Pharmaceutical Industries Ltd.
• Stiefel Laboratories, a GSK Company
• Candela Medical
Key Takeaways from Market Study
• By treatment, retinoid therapy to hold around 40% market value share, globally, primarily due to its effectiveness in controlling the spread of acne as compared to other products and reducing the formation of acne scars.
• Based on route of administration, the topical route of administration is leading with over 60% of market share. Ease of application and greater availability of lotions, creams, and gels are positively driving demand for topical products.
• Inflammatory acne is estimated to dominate the market by type. This segment accounted for approximately 53% share of the market. Significant scarring and pain associated with this type of acne is a key factor driving the segment.
• Institutional sales dominate acne treatment with a market share of 52%. Growing number of dermatology clinics and rising preference toward office-based acne treatment procedures to achieve faster results have created a positive impact on the growth of the market.
• By region, North America is set dominate the global acne treatment market with a value share of around 44%.
• Europe is slated to be the second-largest leading region with a value share of 20% during the forecast period.
"Growing prevalence of acne, preference toward use of combination treatments, and new product launches & approvals are expected to drive market growth over the coming years," says an analyst of Persistence Market Research.
Buy The Complete Report to read the analysed strategies adopted by the top vendors either to retain or gain market share@ https://www.persistencemarketresearch.com/checkout/5279
Market Competition
New product launches and approvals, agreements, collaborations, and partnerships have emerged as the key growth strategy adopted by industry players. By focusing on these strategies, key stakeholders are expanding their geographic footprints and strengthening their existing product portfolios.
In January 2021, Eligo Biosciences SA and GlaxoSmithKline PLC entered into a research collaboration to develop gene therapies to treat or prevent the growth of normal acne.
In February 2020, Almirall S.A. entered into a licensing agreement with Paratek Pharmaceuticals, Inc. to expand Almirall's Seysara in the market in China.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the acne Treatment market in its latest study, presenting historical demand assessment of 2016 - 2020 and projections for 2021 - 2031.
The research study is based on the product (therapeutic treatment [antibiotics, retinoid therapy, hormonal drugs, anti-inflammatory drugs, and chemical peels] and devices [laser devices and radio frequency therapy]), route of administration (topical and oral), acne type (inflammatory and non-Inflammatory acne), distribution channel (institutional sales [hospitals and speciality clinics) and retail sales [retail pharmacies, drug stores, and online sales]), across seven key regions of the world.
For more information about this report visit@ https://www.persistencemarketresearch.com/market-research/acne-treatment-market.asp
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acne Treatment Market is Expected to Reach US$ 10.8 Bn byThe End of 2031, With Sales Revenue Expected to Register 6% CAGR here
News-ID: 2749824 • Views: …
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for Almirall
Dermatological Therapeutics Market May See a Big Move| Almirall, Bausch Health C …
The Latest Released Dermatological Therapeutics market study has evaluated the future growth potential of Dermatological Therapeutics market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges,…
Actinic Keratosis Treatment Market Projected to Show Strong Growth|3M Pharmaceut …
Advance Market Analytics published a new research publication on "Actinic Keratosis Treatment Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Actinic Keratosis Treatment market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample…
AI in Pharmaceutical Market - Major Technology Giants in Buzz Again | AbbVie, Al …
Advance Market Analytics published a new research publication on "AI in Pharmaceutical Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the AI in Pharmaceutical market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample…
Retapamulin Market Size and Share by 2028|Almirall, ,
LOS ANGELES, United States: The global Retapamulin market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Retapamulin market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the…
Porokeratosis Treatment Market Boosting the Growth Worldwide | Almirall, Pfizer, …
The latest study released on the Global Porokeratosis Treatment Market by AMA Research evaluates market size, trend, and forecast to 2027. The Porokeratosis Treatment market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in…
Topical Corticosteroids Market 2019: Competitor Analysis by GlaxoSmithKline plc. …
Databridgemarketresearch.com adds “Topical Corticosteroids Market 2019: Competitor Analysis by GlaxoSmithKline plc., Merck Sharp & Dohme Corp., LEO, Almirall, S.A, Bausch Health, Sandoz International GmbH, Pfizer, Sanofi, AstraZeneca, Almirall, LLC, Godetia Healthcare, Bayer AG” new report to its research database. The report spread across 355 pages with multiple tables and figures in it.
Global Topical Corticosteroids Market By Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone,…